A Reply to ''Evidence that STK19 Is Not an NRAS-Dependent Melanoma Driver"

Chengqian Yin¹, Bo Zhu², Xin Li², Colin R Goding³, Rutao Cui⁴

Affiliations

¹ Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA 02118, USA. Electronic address: yincq323@gmail.com.
² Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA 02118, USA.
³ Ludwig Institute for Cancer Research, University of Oxford, Headington, Oxford OX3 7DQ, UK.
⁴ Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA 02118, USA. Electronic address: rutaocui@bu.edu.

PMID: 32531246
DOI: 10.1016/j.cell.2020.04.029

Free article

Comment

A Reply to ''Evidence that STK19 Is Not an NRAS-Dependent Melanoma Driver"

Chengqian Yin et al. Cell. 2020.

Free article

. 2020 Jun 11;181(6):1406-1409.e2.

doi: 10.1016/j.cell.2020.04.029.

Authors

Chengqian Yin¹, Bo Zhu², Xin Li², Colin R Goding³, Rutao Cui⁴

Affiliations

¹ Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA 02118, USA. Electronic address: yincq323@gmail.com.
² Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA 02118, USA.
³ Ludwig Institute for Cancer Research, University of Oxford, Headington, Oxford OX3 7DQ, UK.
⁴ Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA 02118, USA. Electronic address: rutaocui@bu.edu.

PMID: 32531246
DOI: 10.1016/j.cell.2020.04.029

No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Interests C.Y. and R.C. are co-inventors of a pending patent relating to this work. The other authors declare no competing interests.

Comment on

Pharmacological Targeting of STK19 Inhibits Oncogenic NRAS-Driven Melanomagenesis.
Yin C, Zhu B, Zhang T, Liu T, Chen S, Liu Y, Li X, Miao X, Li S, Mi X, Zhang J, Li L, Wei G, Xu ZX, Gao X, Huang C, Wei Z, Goding CR, Wang P, Deng X, Cui R. Yin C, et al. Cell. 2019 Feb 21;176(5):1113-1127.e16. doi: 10.1016/j.cell.2019.01.002. Epub 2019 Jan 31. Cell. 2019. PMID: 30712867
Evidence That STK19 Is Not an NRAS-dependent Melanoma Driver.
Rodríguez-Martínez M, Boissiére T, Noe Gonzalez M, Litchfield K, Mitter R, Walker J, Kjœr S, Ismail M, Downward J, Swanton C, Svejstrup JQ. Rodríguez-Martínez M, et al. Cell. 2020 Jun 11;181(6):1395-1405.e11. doi: 10.1016/j.cell.2020.04.014. Cell. 2020. PMID: 32531245 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information
Molecular Biology Databases
- GlyGen glycoinformatics resource
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

A Reply to ''Evidence that STK19 Is Not an NRAS-Dependent Melanoma Driver"

Affiliations

A Reply to ''Evidence that STK19 Is Not an NRAS-Dependent Melanoma Driver"

Authors

Affiliations

Conflict of interest statement

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Miscellaneous